Mark VanRaden
- Virology top 2%
- HIV Research and Treatment 4
- Hepatology top 2%
- Parasitology top 1%
- Vector-borne infectious diseases 2
- Infectious Diseases top 2%
- HIV/AIDS Research and Interventions 4
- SARS-CoV-2 and COVID-19 Research 2
- Viral Infections and Outbreaks Research 2
- Epidemiology top 5%
- Hepatitis B Virus Studies 3
- HIV, Drug Use, Sexual Risk 3
-
- Thermal Regulation in Medicine 2
- Co-authors
- Richard A. KaslowLawrence KingsleyRoger DetelsJohn PhairJacqueline C. MelpolderHarvey J. AlterCathy Conry‐CantilenaL Viladomiu
- Cited by
- VirologyHepatologyParasitology
- Partner nations
- United StatesVietnamSpain
In The Last Decade
Mark VanRaden
20 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Virology 296
- Hepatology 490
- Parasitology 355
- Infectious Diseases 900
- Epidemiology 825
Countries citing papers authored by Mark VanRaden
This map shows the geographic impact of Mark VanRaden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark VanRaden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark VanRaden more than expected).
Fields of papers citing papers by Mark VanRaden
This network shows the impact of papers produced by Mark VanRaden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark VanRaden. The network helps show where Mark VanRaden may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark VanRaden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 15 | |
| 2 | 2017 | 7 | |
| 3 | 2016 | 10 | |
| 4 | 2016 | 11 | |
| 5 | 2014 | 55 | |
| 6 | 2013 | 13 | |
| 7 | 2007 | 101 | |
| 8 | 2006 | 259 | |
| 9 | 2006 | 1 | |
| 10 | Estimation of pertussis vaccine efficacy in the presence of covariates in three randomized trials. | 1997 | 1 |
| 11 | Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infectionbreakdown → | 1996 | 510 |
| 12 | 1995 | 5 | |
| 13 | 1993 | 6 | |
| 14 | 1991 | 67 | |
| 15 | 1990 | 92 | |
| 16 | 1990 | 36 | |
| 17 | 1990 | 166 | |
| 18 | 1990 | 72 | |
| 19 | 1989 | 172 | |
| 20 | 1987 | 248 |
About Mark VanRaden
Mark VanRaden is a scholar working on Virology, Infectious Diseases, Critical Care and Intensive Care Medicine, Parasitology and Hepatology, having authored 20 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (4 papers), HIV/AIDS Research and Interventions (4 papers), Hepatitis B Virus Studies (3 papers), HIV, Drug Use, Sexual Risk (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Thermal Regulation in Medicine (2 papers), Viral Infections and Outbreaks Research (2 papers) and Vector-borne infectious diseases (2 papers). The work is most often cited by research in Virology (296 citations), Hepatology (490 citations), Parasitology (355 citations), Infectious Diseases (900 citations) and Epidemiology (825 citations). Mark VanRaden has collaborated with scholars based in United States, Vietnam and Spain. Frequent co-authors include Richard A. Kaslow, Lawrence Kingsley, Roger Detels, John Phair, Jacqueline C. Melpolder, Harvey J. Alter, Cathy Conry‐Cantilena, L Viladomiu, A. Obaid Shakil and Jay H. Hoofnagle. Their work appears in journals such as Vaccine, New England Journal of Medicine, The Lancet, Molecular Microbiology and Journal of the American Academy of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.